Request Demo
Last update 16 May 2025
ZG-19018
Last update 16 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms ZG 19018, ZG-19018, ZG19018 |
Target |
Action inhibitors |
Mechanism KRAS G12C inhibitors(GTPase KRas G12C inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with ZG-19018NCT06237400
A Phase I/II Dose Escalation and Expansion Study to Evaluating the Tolerability, Safety, Efficacy, and Pharmacokinetics of ZG19018 in Patients With KRAS G12C Mutant Advanced Solid Tumors.
100 Clinical Results associated with ZG-19018
Login to view more data
100 Translational Medicine associated with ZG-19018
Login to view more data
100 Patents (Medical) associated with ZG-19018
Login to view more data
100 Deals associated with ZG-19018
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| KRAS G12C mutation Solid Tumors | Phase 2 | China | 26 May 2022 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 28 Apr 2022 | |
| Colorectal Cancer | Phase 2 | China | 28 Apr 2022 | |
| KRAS G12C mutant Non-small Cell Lung Cancer | Phase 2 | China | 28 Apr 2022 | |
| KRAS mutation-related tumors | Phase 2 | China | 28 Apr 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1/2 | 14 | vymjndwgto(aicucrninq) = ionungwmtd obiqhcvcmh (oaepvqfqom ) View more | Positive | 26 May 2023 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free